Immunohistochemistry showed positivity for estrogen and progesterone receptors (81%) and negativity for Her2 (93%), there has been reported less than 5% of patients with lymph node metastases [4,11,13]. The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.